Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma

Pinggui Chen,1 Yaoxuan Li,2 Yunyan Dai,1 Zhiming Wang,1 Yunpeng Zhou,1 Yi Wang,1 Gaopeng Li1 1Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, People’s Republic of China; 2Department of Sc...

Full description

Bibliographic Details
Main Authors: Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Online Access:https://www.dovepress.com/advances-in-the-pathogenesis-of-metabolic-liver-disease-related-hepato-peer-reviewed-fulltext-article-JHC
_version_ 1827314223511764992
author Chen P
Li Y
Dai Y
Wang Z
Zhou Y
Wang Y
Li G
author_facet Chen P
Li Y
Dai Y
Wang Z
Zhou Y
Wang Y
Li G
author_sort Chen P
collection DOAJ
description Pinggui Chen,1 Yaoxuan Li,2 Yunyan Dai,1 Zhiming Wang,1 Yunpeng Zhou,1 Yi Wang,1 Gaopeng Li1 1Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, People’s Republic of China; 2Department of School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaCorrespondence: Gaopeng Li, Email malone2001@163.comAbstract: Hepatocellular carcinoma (HCC) is the sixth most common cancer globally and the primary cause of death in cancer cases, with significant public health concern worldwide. Despite the overall decline in the incidence and mortality rates of HCC in recent years in recent years, the emergence of metabolic liver disease-related HCC is causing heightened concern, especially in countries like the United States, the United Kingdom, and P.R. China. The escalation of metabolic liver disease-related HCC is attributed to a combination of factors, including genetic predisposition, lifestyle choices, and changes in the living environment. However, the pathogenesis of metabolic liver disease-associated HCC remains imperfect. In this review, we encapsulate the latest advances and essential aspects of the pathogenesis of metabolic liver disease-associated HCC, including alcoholic liver disease (ALD), metabolic dysfunction–associated steatotic liver disease (MASLD), and inherited metabolic liver diseases.Keywords: hepatocellular carcinoma, metabolic liver disease, pathogenesis, alcoholic liver disease, metabolic dysfunction–associated steatotic liver disease
first_indexed 2024-04-24T22:31:12Z
format Article
id doaj.art-129b726403f044c1b7c6ca64c814fa57
institution Directory Open Access Journal
issn 2253-5969
language English
last_indexed 2024-04-24T22:31:12Z
publishDate 2024-03-01
publisher Dove Medical Press
record_format Article
series Journal of Hepatocellular Carcinoma
spelling doaj.art-129b726403f044c1b7c6ca64c814fa572024-03-19T17:12:19ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692024-03-01Volume 1158159491356Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular CarcinomaChen PLi YDai YWang ZZhou YWang YLi GPinggui Chen,1 Yaoxuan Li,2 Yunyan Dai,1 Zhiming Wang,1 Yunpeng Zhou,1 Yi Wang,1 Gaopeng Li1 1Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, People’s Republic of China; 2Department of School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaCorrespondence: Gaopeng Li, Email malone2001@163.comAbstract: Hepatocellular carcinoma (HCC) is the sixth most common cancer globally and the primary cause of death in cancer cases, with significant public health concern worldwide. Despite the overall decline in the incidence and mortality rates of HCC in recent years in recent years, the emergence of metabolic liver disease-related HCC is causing heightened concern, especially in countries like the United States, the United Kingdom, and P.R. China. The escalation of metabolic liver disease-related HCC is attributed to a combination of factors, including genetic predisposition, lifestyle choices, and changes in the living environment. However, the pathogenesis of metabolic liver disease-associated HCC remains imperfect. In this review, we encapsulate the latest advances and essential aspects of the pathogenesis of metabolic liver disease-associated HCC, including alcoholic liver disease (ALD), metabolic dysfunction–associated steatotic liver disease (MASLD), and inherited metabolic liver diseases.Keywords: hepatocellular carcinoma, metabolic liver disease, pathogenesis, alcoholic liver disease, metabolic dysfunction–associated steatotic liver diseasehttps://www.dovepress.com/advances-in-the-pathogenesis-of-metabolic-liver-disease-related-hepato-peer-reviewed-fulltext-article-JHChepatocellular carcinomametabolic liver diseasepathogenesisalcoholic liver diseasemetabolic dysfunction–associated steatotic liver disease
spellingShingle Chen P
Li Y
Dai Y
Wang Z
Zhou Y
Wang Y
Li G
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
hepatocellular carcinoma
metabolic liver disease
pathogenesis
alcoholic liver disease
metabolic dysfunction–associated steatotic liver disease
title Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
title_full Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
title_fullStr Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
title_full_unstemmed Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
title_short Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
title_sort advances in the pathogenesis of metabolic liver disease related hepatocellular carcinoma
topic hepatocellular carcinoma
metabolic liver disease
pathogenesis
alcoholic liver disease
metabolic dysfunction–associated steatotic liver disease
url https://www.dovepress.com/advances-in-the-pathogenesis-of-metabolic-liver-disease-related-hepato-peer-reviewed-fulltext-article-JHC
work_keys_str_mv AT chenp advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma
AT liy advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma
AT daiy advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma
AT wangz advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma
AT zhouy advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma
AT wangy advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma
AT lig advancesinthepathogenesisofmetabolicliverdiseaserelatedhepatocellularcarcinoma